Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US10265311B2 · kind B2 · utility
9Cited by
18References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2016 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Dec 14, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the treatment of CNS disorders using combinations of muscarinic activators and inhibitors, and medicaments comprising muscarinic activators and inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.